MedPath

Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic Shock

Not Applicable
Withdrawn
Conditions
Bacterial Sepsis
Registration Number
NCT03343041
Lead Sponsor
Yale University
Brief Summary

This pilot study aims to test the tolerability of low-carbohydrate enteral nutrition in patients with bacterial septic shock.

Detailed Description

This study seeks to assess the tolerability of utilizing low-carbohydrate nutrition in patients admitted to the MICU with bacterial septic shock. Low carbohydrate feeds have been used before in the critical care setting and were well-tolerated.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Patients aged 18-65 admitted to the MICU with a diagnosis of severe sepsis or septic shock
  2. Patients with 35 > BMI > 18.5
  3. Patients with serum pro-calcitonin > 1 ng/mL in the first 24 hours of hospitalization
Exclusion Criteria
  1. Patients with chronic kidney disease as defined by glomerular filtration rate < 60 for > 6 months
  2. Patients with chronic liver disease as defined by radiographic or tissue evidence of cirrhosis or persistently abnormal liver function tests for > 6 months
  3. Patients with current malignancies
  4. Patients with autoimmune disease on current immunotherapy
  5. Patients on corticosteroids at doses of prednisone or prednisone-equivalents > 5 mg for > 6 months
  6. Patients with weight-reduction surgeries
  7. Patients with positive viral studies in the first 24 hours of admission

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Length of stay (LOS) in the ICU.discharge: average 5 days.

The primary clinical outcome will be to reduce the length of stay (LOS) in the ICU. Average length of stay is 5 days.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yale New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Yale New Haven Hospital
🇺🇸New Haven, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.